Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Yikang Biotech (suzhou) Co., Ltd.

Clinical trials sponsored by Yikang Biotech (suzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new vaccine shield adults from RSV? Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Can a new vaccine shield adults from RSV?

Vaccine Not yet recruiting

Researchers are testing an experimental vaccine against respiratory syncytial virus (RSV) in adults aged 18 and older. The trial aims to see if the vaccine is safe and whether it triggers an immune response. Participants receive one of several vaccine formulations or a placebo, a…

Phase 1 • Sponsor: Yikang Biotech (Suzhou) Co., Ltd. • Aim: Vaccine

Last updated Sep 09, 2026 16:00 UTC